AI Vision Correction System

Ik Hee Ryu, MD, MS from B&VIIT Eye Center is speaking at a conference of B&VIIT AI.

Based on 26 years of surgical experience and accumulated vision correction data of 450,000 eyes, we derive the result value and propose an optimized vision correction method objectively.

B&VIIT AI Report

We perceive over 80% of external information through our eyes. It is inevitable that poor vision would degrade quality of life. Neuroscientists report that the eyes play a crucial role in brain-related disease, including dementia, Parkinson’s disease, and autism. This would indicate that the organ that best represents the brain is the eye. Even toContinue reading “B&VIIT AI Report”

TVST_January, 2020

In January, 2020, the research paper of B&VIIT AI was published in TVST(Transitional Vision Science & Technology) under the subject of ‘Explainable Machine Learning Approach as a Tool to Understand Factors Used to Select the Refractive Surgery Technique on the Expert Level.’

Nature Digital Medicine_June, 2019

In June, 2019, the research paper of B&VIIT AI R&D was published in the npj Digital Medicine under the name of Nature Medicine for the first time in the ophthalmology field in Korea.

Beyond Vision Correction

People often view the current generation of vision correction as the fourth. However, we proudly proclaim that we are in the fifth generation of vision correction, considering the fact that we have gone beyond the distinction of generations with regard to both experience and equipment and have reached an age when artificial intelligence plays aContinue reading “Beyond Vision Correction”

B&VIIT AI is really revolutionizing, and it will be implemented through medicine in the very near future.

– William Schiff, OD

“Here is a step into the future. I was very impressed by the technology you developed in both way you created this AI system and the way you are able to gather the data from all those different equipment. This is a great step ahead.”

– Andrea Russo, MD, PhD

B&VIIT Eye Center is one of the light houses in refractive surgery. I think you are over the produced portfolio that patients can have.”

Andre Narr, Carl Zeiss Meditec AG

%d bloggers like this: